Chronic hepatitis B infection and risk of atherosclerosis-related mortality: A 17-year follow-up study based on 22,472 residents in Taiwan

Atherosclerosis

Volumn 211, Issue 2, 2010, Pages 624-629

  Wang, Chih Hao ^a   Chen, Chien Jen ^b,c   Lee, Mei Hsuan ^b   Yang, Hwai I ^c   Hsiao, Chuhsing Kate ^b  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

Atherosclerosis related mortality; Competing risk of liver mortality; Hepatitis B infection

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEPATITIS B; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; TAIWAN;

ADULT; AGED; ATHEROSCLEROSIS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK; TAIWAN;

EID: 77955282119     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.03.008     Document Type: Article

References (26)

1. Vita J.A., Loscalzo J. Shouldering the risk factor burden: infection, atherosclerosis, and the vascular endothelium. Circulation 2002, 106:164-166.
2. Wilson P.W., D'Agostino R.B., Levy D., et al. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.
3. Epstein S.E., Zhu J., Najafi A.H., Burnet M.S. Insights into the role of infection in atherogenesis and in mechanistic paradigms. Circulation 2009, 119:3133-3314.
4. Adam E., Melnick J.L., Probtsfield J.L., et al. High level of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987, 2:291-293.
5. Saikku P., Leinonen M., Mattila K., et al. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 1988, 2:983-986.
6. Shah P.K. Link between infection and atherosclerosis: who are the culprits: viruses, bacteria, both, or neither?. Circulation 2001, 103:5-6.
7. Ishizaka N., Ishizaka Y., Takahashi E., et al. Increased prevalence of carotid atherosclerosis in hepatitis B virus carriers. Circulation 2002, 105:1028-1030.
8. Kiechl S., Egger G., Mayr M., et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001, 103:1064-1070.
9. Ishizaka N., Ishizaka Y., Takahashi E., et al. Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet 2002, 359:133-135.
10. Tomiyama H., Arai T., Hirose K., et al. Hepatitis C virus seropositivity, but not hepatitis B virus carrier or seropositivity, associated with increased pulse wave velocity. Atherosclerosis 2003, 166:401-403.
11. Ridker P.M., Hennekens C.H., Stanpfer M.J., Wang F. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation 1998, 98:2796-2799.
12. Völzke H., Schwahn C., Wolff B., et al. Hepatitis B and C virus infection and the risk of atherosclerosis in a general population. Atherosclerosis 2004, 174:99-103.
13. Tong D.Y., Wang X.H., Xu C.F., et al. Hepatitis B virus infection and coronary atherosclerosis: results from a population with relatively high prevalence of hepatitis B virus. World J Gastroenterol 2005, 11:1292-1296.
14. Bilora F., Rinaldi R., Boccioletti V., et al. A. Chronic viral hepatitis: a prospective factor against atherosclerosis. A study with echo-color Doppler of the carotid and femoral arteries and the abdominal aorta. Gastroenterol Clin Biol 2002, 26:1001-1004.
15. Yang K.C., Chen M.F., Su T.C., et al. Hepatitis B virus seropositivity is not associated with increased risk of carotid atherosclerosis in Taiwanese. Atherosclerosis 2007, 195:392-397.
16. Amin J., Law M.G., Bartlett M., et al. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 2006, 368:938-945.
17. Sung J., Song Y.M., Choi Y.H., et al. Hepatitis B virus seropositivity and the risk of stroke and myocardial infarction. Stroke 2007, 38:1436-1441.
18. Lee W.M. Hepatitis B virus infection. N Engl J Med 1997, 337:1733-1745.
19. Chen CJ, Yang HI, Su J, et al. for the REVEAL-HBV Study Group. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65-73.
20. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
21. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Kidney Disease Outcome Quality Initiative. Am J Kidney Dis 2002, 39:S1-S246.
22. Fine J.P., Gray R.J. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999, 94:496-509.
23. Hu H.H., Chu F.L., Chiang B.N., et al. Prevalence of stroke in Taiwan. Stroke 1989, 20:858-863.
24. Prasad A., Zhu J., Halcox J.P., et al. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation 2002, 106:184-190.
25. Zhu J., Nieto F.J., Horne B.D., et al. Prospective study of pathogen burden and risk of myocardial infarction or death. Circulation 2001, 103:45-51.
26. Rupprecht H.J., Blankenberg S., Bickel C., et al. Impact of viral and bacterial infectious burden on long-term prognosis in patients with coronary artery disease. Circulation 2001, 104:25-31.